Showing results (631-640 of 672) with videos related to

Sort By:
Pageof 68
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2012
Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: results from a randomized trialJürgen Finke, Claudia Schmoor, Wolfgang A Bethge, et al.
Nature Communications|July 30, 2021
Antibody toolkit reveals N-terminally ubiquitinated substrates of UBE2WChristopher W Davies, Simon E Vidal, Lilian Phu, et al.
Internet Interventions|September 15, 2022
Online consultations in mental healthcare: Modelling determinants of use and experience based on an international survey study at the onset of the pandemicTom Van Daele, Kim Mathiasen, Per Carlbring, et al.
Blood|February 26, 2004
Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantationNicolaus Kröger, Georgia Schilling, Hermann Einsele, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2004
Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myelomaNicolaus Kröger, Jose A Perez-Simon, Han Myint, et al.
Leukemia|January 8, 2021
A modular and controllable T cell therapy platform for acute myeloid leukemiaMohamed-Reda Benmebarek, Bruno L Cadilha, Monika Herrmann, et al.
Blood|December 18, 2010
Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapyChristian Straka, Michael Sandherr, Hans Salwender, et al.
Leukemia|February 5, 2021
Allogeneic hematopoietic stem cell transplantation for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 B-cell precursor acute lymphoblastic leukemia in first complete remission: impact of pretransplant measurable residual disease (MRD) status. An analysis from the Acute Leukemia Working Party of the EBMTJordi Esteve, Sebastian Giebel, Myriam Labopin, et al.
Bone Marrow Transplantation|November 8, 2016
Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMTM Robin, R Porcher, W Zinke-Cerwenka, et al.
Journal of Medicinal Chemistry|April 15, 2005
Pyridinium-1-yl bisphosphonates are potent inhibitors of farnesyl diphosphate synthase and bone resorptionJohn M Sanders, Yongcheng Song, Julian M W Chan, et al.
Pageof 68